Atomwise

Biotechnology

Atomwise uses artificial intelligence and deep learning to predict which drug molecules will bind to target proteins, accelerating early-stage drug discovery. The company has screened trillions of potential compounds in silico. Atomwise's AI-driven approach aims to reduce the time and cost of finding promising drug candidates.